Hi everyone,
It was wonderful seeing everyone in Berlin! As a follow-up to our discussion and as promised, sharing with you the attached pre-print from one of our colleagues (Darmendra Ramcharran, GSK).
The paper outlines the development and application of a series of guardrails aimed at mitigating risks and improving the reliability of LLM outputs particularly in the realm of pharmacovigilance though these same guardrails could be considered for all types of RWE research.
Also, if you are interested, here is an AI-generated 10 minute podcast developed by Google's NotebookLM (LINK) that talks about the paper (@Darmendra, you can tell me how accurate this is!).
Thanks everyone and talk soon!
------------------------------
John Diaz-Decaro
Latent Virus, Epidemiology Lead
ModernaTX, Inc.
email:
john.diaz-decaro@modernatx.comVice Chair
Digital Epidemiology Special Interest Group
------------------------------